Plasma glutamine and glutamic acid are potential biomarkers for predicting diabetic retinopathy.
Sang Youl RheeEun Sung JungHye Min ParkSu Jin JeongKiyoung KimSuk ChonSeung-Young YuJeong Taek WooChoong Hwan LeePublished in: Metabolomics : Official journal of the Metabolomic Society (2018)
Our results imply that plasma glutamine, glutamic acid, and their ratio may be valuable as novel biomarkers for anticipating DR in T2D subjects.